Short term question is - when? Do we see the SP flat line here and slowly decline as people lose interest waiting - or is there an appetite for continuing accumulation.
I am hoping for a pre-Phase3 deal soon. If Neuren go it alone then we are looking at end 2018 for results and then we still need a deal. I can't see Neuren penetrating the market without the sales and manufacturing horsepower of the big boys.
Speed to market is a stated primary goal, and I can't see a solution without big pharma in meeting this objective. Partnering at this point makes the most sense IMO. Lets hope Santa brings us a the big one this year!
Short term question is - when? Do we see the SP flat line here...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |